Search research articles
Contact Us
Filters
Showing results (91-100 of 266) with videos related to
Page
of 27
Sort By:
Expert Review of Gastroenterology & Hepatology
|
August 17, 2021
Clinical utility of clonal origin determination in managing recurrent hepatocellular carcinoma
Shubham Gupta, Sikandar Khan, Michal Kawka, et al.
BMC Cancer
|
August 2, 2012
Peri-operative chemotherapy in the management of resectable colorectal cancer pulmonary metastases
Eliza A Hawkes, George Ladas, David Cunningham, et al.
BMC Gastroenterology
|
May 7, 2020
Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancer
David Gómez-Ulloa, Mayur Amonkar, Smita Kothari, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 29, 2011
Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancer
Eliza Hawkes, Alicia F C Okines, Demetris Papamichael, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 4, 2020
Impact of sex and age on chemotherapy efficacy, toxicity and survival in localised oesophagogastric cancer: A pooled analysis of 3265 individual patient data from four large randomised trials (OE02, OE05, MAGIC and ST03)
Avani Athauda, Matthew Nankivell, Ruth E Langley, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
July 14, 2025
Impact of perioperative fluorouracil, leucovorin, oxaliplatin, and docetaxel delivery on postoperative survival in locally advanced oesophagogastric adenocarcinoma
Keiji Sugiyama, Sacheen Kumar, Asif Chaudry, et al.
Cancers
|
March 15, 2020
Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clinical Practice: OZONE Study
Ian Chau, Marwan Fakih, Pilar García-Alfonso, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 18, 2018
Association of quality of life with disease characteristics and treatment outcomes in patients with advanced gastric cancer: Exploratory analysis of RAINBOW and REGARD phase III trials
Ian Chau, Charles S Fuchs, Atsushi Ohtsu, et al.
The Oncologist
|
October 16, 2016
Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging
Khurum Khan, Avani Athauda, Katharine Aitken, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 23, 2019
Influence of sex on chemotherapy efficacy and toxicity in oesophagogastric cancer: A pooled analysis of four randomised trials
Michael Davidson, Anna Dorothea Wagner, Kyriakos Kouvelakis, et al.
Page
of 27
Search research articles
Search
Showing results (91-100 of 266) with videos related to
Sort By:
Page
of 27
Expert Review of Gastroenterology & Hepatology
|
August 17, 2021
Clinical utility of clonal origin determination in managing recurrent hepatocellular carcinoma
Shubham Gupta, Sikandar Khan, Michal Kawka, et al.
BMC Cancer
|
August 2, 2012
Peri-operative chemotherapy in the management of resectable colorectal cancer pulmonary metastases
Eliza A Hawkes, George Ladas, David Cunningham, et al.
BMC Gastroenterology
|
May 7, 2020
Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancer
David Gómez-Ulloa, Mayur Amonkar, Smita Kothari, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 29, 2011
Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancer
Eliza Hawkes, Alicia F C Okines, Demetris Papamichael, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 4, 2020
Impact of sex and age on chemotherapy efficacy, toxicity and survival in localised oesophagogastric cancer: A pooled analysis of 3265 individual patient data from four large randomised trials (OE02, OE05, MAGIC and ST03)
Avani Athauda, Matthew Nankivell, Ruth E Langley, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
July 14, 2025
Impact of perioperative fluorouracil, leucovorin, oxaliplatin, and docetaxel delivery on postoperative survival in locally advanced oesophagogastric adenocarcinoma
Keiji Sugiyama, Sacheen Kumar, Asif Chaudry, et al.
Cancers
|
March 15, 2020
Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clinical Practice: OZONE Study
Ian Chau, Marwan Fakih, Pilar García-Alfonso, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 18, 2018
Association of quality of life with disease characteristics and treatment outcomes in patients with advanced gastric cancer: Exploratory analysis of RAINBOW and REGARD phase III trials
Ian Chau, Charles S Fuchs, Atsushi Ohtsu, et al.
The Oncologist
|
October 16, 2016
Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging
Khurum Khan, Avani Athauda, Katharine Aitken, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 23, 2019
Influence of sex on chemotherapy efficacy and toxicity in oesophagogastric cancer: A pooled analysis of four randomised trials
Michael Davidson, Anna Dorothea Wagner, Kyriakos Kouvelakis, et al.
Page
of 27